Dr. Soroush Bazargani, MD

Dr. Bazargani practices at Kern County Hospital Authority in Bakersfield, California.

Dr. Bazargani's NPI, 1053859041, was assigned on February 9, 2017. Dr. Bazargani graduated from Tehran University of Medical Sciences School of Medicine in 2002. Dr. Bazargani holds California license A171098.

Dr. Bazargani's primary practice is Kern County Hospital Authority, at 1700 Mt Vernon Ave, Bakersfield, CA 93306 in Kern County. The practice phone is (661) 326-2000.

Dr. Bazargani's primary practice is Kern County Hospital Authority in Bakersfield, California. Dr. Bazargani is also affiliated with Adventist Health Bakersfield. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Bazargani to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bazargani practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bazargani's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Bazargani's licenses on file in 2 states: California and Florida.

CMS data shows 473 Medicare services from Dr. Bazargani across 12 procedure codes in 2024, for 265 Medicare patients. Medicare paid $56,619 for them.

CMS counts 265 Medicare patients who saw Dr. Bazargani in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bazargani's median patient age at 57, with 22% women.

In 2024, Dr. Bazargani wrote 309 Medicare Part D claims for 99 patients. 95% of them were for generic drugs. CMS names the drug for 231 of them, across 7 drugs with 11 or more claims each, at $2,411 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Bazargani for performance year 2024, reported through an alternative payment model (APM). Dr. Bazargani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of prostate resection by Dr. Bazargani, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Bazargani, published from 2010 to 2023. 2020 was the busiest year, with 4. The most frequent topics are Magnetic Resonance Imaging, Postoperative Complications and Prostatic Neoplasms. Dr. Bazargani has published most often in Urol Oncol. Dr. Bazargani's most frequent co-authors are Kethandapatti Chakravarthy Balaji, MBBS, Mark G. Bandyk, MD and Jatinder Kumar.

CMS Open Payments shows 60 general payments to Dr. Bazargani from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 62% of the total. Photocure Inc paid the most, $2,006.

Dr. Bazargani graduated from Tehran University of Medical Sciences School of Medicine in 2002.

Dr. Bazargani is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.